View in EDS HTML Full Text PDF Full Text

Cardiometabolic outcomes with dapagliflozin after myocardial infarction by baseline ejection fraction: DAPA-MI.

Saved in:
Bibliographic Details
Title: Cardiometabolic outcomes with dapagliflozin after myocardial infarction by baseline ejection fraction: DAPA-MI.
Authors: Erlinge D; Department of Cardiology, Clinical Sciences, Lund University, Lund, Sweden., James S; Uppsala Clinical Research Center, Uppsala, Sweden.; Department of Medical Sciences, Cardiology, Uppsala University, Uppsala, Sweden., Deanfield J; Institute of Cardiovascular Sciences, University College London, London, UK., Eriksson N; Uppsala Clinical Research Center, Uppsala, Sweden., de Belder M; National Institute for Cardiovascular Outcomes Research (NICOR), NHS Arden and Greater East Midlands Commissioning Support Unit, Leicester, UK., Alchay M; North Älvsborg County Hospital, Trollhättan, Sweden., Austin D; Academic Cardiovascular Unit, The James Cook University Hospital, South Tees Hospitals NHS Foundation Trust, Middlesbrough, UK.; Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK., Jones DA; William Harvey Research Institute, Barts and The London Faculty of Medicine and Dentistry, Queen Mary University of London, London, UK.; Department of Cardiology, St Bartholomew's Hospital, West Smithfield, London, UK., Ravn-Fischer A; Institute of Medicine, Department of Molecular and Clinical Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Department of Cardiology, Sahlgrenska University Hospital, Gothenburg, Sweden., Sederholm Lawesson S; Department of Health, Medicine and Caring Sciences, Linköping University, Linköping, Sweden.; Department of Cardiology, Linköping University Hospital, Linköping, Sweden., Shah N; Queen Alexandra Hospital, Portsmouth, UK., Strange JW; Department of Cardiology, Bristol Heart Institute, University Hospital Bristol NHS Foundation Trust, Bristol, UK.; Weston Area Health NHS Trust, Bristol, UK., Szummer K; Department of Cardiology, Karolinska University Hospital, Huddinge, Stockholm, Sweden.; Department of Medicine, Karolinska Institutet, Stockholm, Sweden., Ridderstråle W; Late-Stage Development, Cardiovascular, Renal and Metabolism, Bio-Pharmaceuticals Research and Development, AstraZeneca, Gothenburg, Sweden., Parvaresh Rizi E; Late-Stage Development, Cardiovascular, Renal and Metabolism, Bio-Pharmaceuticals Research and Development, AstraZeneca, Gothenburg, Sweden., Langkilde AM; Late-Stage Development, Cardiovascular, Renal and Metabolism, Bio-Pharmaceuticals Research and Development, AstraZeneca, Gothenburg, Sweden., Johansson PA; Late-Stage Development, Cardiovascular, Renal and Metabolism, Bio-Pharmaceuticals Research and Development, AstraZeneca, Gothenburg, Sweden., McGuire DK; Division of Cardiology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA.; Division of Cardiology, Parkland Health System, Dallas, Texas, USA., Oldgren J; Uppsala Clinical Research Center, Uppsala, Sweden.; Department of Medical Sciences, Cardiology, Uppsala University, Uppsala, Sweden., Storey RF; Division of Clinical Medicine, University of Sheffield, Sheffield, UK.; NIHR Sheffield Biomedical Research Centre, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.
Source: ESC heart failure [ESC Heart Fail] 2025 Dec; Vol. 12 (6), pp. 4184-4193. Date of Electronic Publication: 2025 Sep 16.
Publication Type: Journal Article; Randomized Controlled Trial; Multicenter Study
Journal Info: Publisher: John Wiley & Sons Ltd on behalf of the European Society of Cardiology Country of Publication: England NLM ID: 101669191 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2055-5822 (Electronic) Linking ISSN: 20555822 NLM ISO Abbreviation: ESC Heart Fail Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40958495
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Cardiometabolic outcomes with dapagliflozin after myocardial infarction by baseline ejection fraction: DAPA-MI.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Erlinge+D%22">Erlinge D</searchLink>; Department of Cardiology, Clinical Sciences, Lund University, Lund, Sweden.<br /><searchLink fieldCode="AU" term="%22James+S%22">James S</searchLink>; Uppsala Clinical Research Center, Uppsala, Sweden.; Department of Medical Sciences, Cardiology, Uppsala University, Uppsala, Sweden.<br /><searchLink fieldCode="AU" term="%22Deanfield+J%22">Deanfield J</searchLink>; Institute of Cardiovascular Sciences, University College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Eriksson+N%22">Eriksson N</searchLink>; Uppsala Clinical Research Center, Uppsala, Sweden.<br /><searchLink fieldCode="AU" term="%22de+Belder+M%22">de Belder M</searchLink>; National Institute for Cardiovascular Outcomes Research (NICOR), NHS Arden and Greater East Midlands Commissioning Support Unit, Leicester, UK.<br /><searchLink fieldCode="AU" term="%22Alchay+M%22">Alchay M</searchLink>; North Älvsborg County Hospital, Trollhättan, Sweden.<br /><searchLink fieldCode="AU" term="%22Austin+D%22">Austin D</searchLink>; Academic Cardiovascular Unit, The James Cook University Hospital, South Tees Hospitals NHS Foundation Trust, Middlesbrough, UK.; Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK.<br /><searchLink fieldCode="AU" term="%22Jones+DA%22">Jones DA</searchLink>; William Harvey Research Institute, Barts and The London Faculty of Medicine and Dentistry, Queen Mary University of London, London, UK.; Department of Cardiology, St Bartholomew's Hospital, West Smithfield, London, UK.<br /><searchLink fieldCode="AU" term="%22Ravn-Fischer+A%22">Ravn-Fischer A</searchLink>; Institute of Medicine, Department of Molecular and Clinical Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Department of Cardiology, Sahlgrenska University Hospital, Gothenburg, Sweden.<br /><searchLink fieldCode="AU" term="%22Sederholm+Lawesson+S%22">Sederholm Lawesson S</searchLink>; Department of Health, Medicine and Caring Sciences, Linköping University, Linköping, Sweden.; Department of Cardiology, Linköping University Hospital, Linköping, Sweden.<br /><searchLink fieldCode="AU" term="%22Shah+N%22">Shah N</searchLink>; Queen Alexandra Hospital, Portsmouth, UK.<br /><searchLink fieldCode="AU" term="%22Strange+JW%22">Strange JW</searchLink>; Department of Cardiology, Bristol Heart Institute, University Hospital Bristol NHS Foundation Trust, Bristol, UK.; Weston Area Health NHS Trust, Bristol, UK.<br /><searchLink fieldCode="AU" term="%22Szummer+K%22">Szummer K</searchLink>; Department of Cardiology, Karolinska University Hospital, Huddinge, Stockholm, Sweden.; Department of Medicine, Karolinska Institutet, Stockholm, Sweden.<br /><searchLink fieldCode="AU" term="%22Ridderstråle+W%22">Ridderstråle W</searchLink>; Late-Stage Development, Cardiovascular, Renal and Metabolism, Bio-Pharmaceuticals Research and Development, AstraZeneca, Gothenburg, Sweden.<br /><searchLink fieldCode="AU" term="%22Parvaresh+Rizi+E%22">Parvaresh Rizi E</searchLink>; Late-Stage Development, Cardiovascular, Renal and Metabolism, Bio-Pharmaceuticals Research and Development, AstraZeneca, Gothenburg, Sweden.<br /><searchLink fieldCode="AU" term="%22Langkilde+AM%22">Langkilde AM</searchLink>; Late-Stage Development, Cardiovascular, Renal and Metabolism, Bio-Pharmaceuticals Research and Development, AstraZeneca, Gothenburg, Sweden.<br /><searchLink fieldCode="AU" term="%22Johansson+PA%22">Johansson PA</searchLink>; Late-Stage Development, Cardiovascular, Renal and Metabolism, Bio-Pharmaceuticals Research and Development, AstraZeneca, Gothenburg, Sweden.<br /><searchLink fieldCode="AU" term="%22McGuire+DK%22">McGuire DK</searchLink>; Division of Cardiology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA.; Division of Cardiology, Parkland Health System, Dallas, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Oldgren+J%22">Oldgren J</searchLink>; Uppsala Clinical Research Center, Uppsala, Sweden.; Department of Medical Sciences, Cardiology, Uppsala University, Uppsala, Sweden.<br /><searchLink fieldCode="AU" term="%22Storey+RF%22">Storey RF</searchLink>; Division of Clinical Medicine, University of Sheffield, Sheffield, UK.; NIHR Sheffield Biomedical Research Centre, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101669191%22">ESC heart failure</searchLink> [ESC Heart Fail] 2025 Dec; Vol. 12 (6), pp. 4184-4193. <i>Date of Electronic Publication: </i>2025 Sep 16.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Randomized Controlled Trial; Multicenter Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22John+Wiley+%26+Sons+Ltd+on+behalf+of+the+European+Society+of+Cardiology%22">John Wiley & Sons Ltd on behalf of the European Society of Cardiology </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101669191 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2055-5822 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220555822%22">20555822 </searchLink><i>NLM ISO Abbreviation: </i>ESC Heart Fail <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40958495
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/ehf2.15420
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 4184
    Titles:
      – TitleFull: Cardiometabolic outcomes with dapagliflozin after myocardial infarction by baseline ejection fraction: DAPA-MI.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Erlinge D
      – PersonEntity:
          Name:
            NameFull: James S
      – PersonEntity:
          Name:
            NameFull: Deanfield J
      – PersonEntity:
          Name:
            NameFull: Eriksson N
      – PersonEntity:
          Name:
            NameFull: de Belder M
      – PersonEntity:
          Name:
            NameFull: Alchay M
      – PersonEntity:
          Name:
            NameFull: Austin D
      – PersonEntity:
          Name:
            NameFull: Jones DA
      – PersonEntity:
          Name:
            NameFull: Ravn-Fischer A
      – PersonEntity:
          Name:
            NameFull: Sederholm Lawesson S
      – PersonEntity:
          Name:
            NameFull: Shah N
      – PersonEntity:
          Name:
            NameFull: Strange JW
      – PersonEntity:
          Name:
            NameFull: Szummer K
      – PersonEntity:
          Name:
            NameFull: Ridderstråle W
      – PersonEntity:
          Name:
            NameFull: Parvaresh Rizi E
      – PersonEntity:
          Name:
            NameFull: Langkilde AM
      – PersonEntity:
          Name:
            NameFull: Johansson PA
      – PersonEntity:
          Name:
            NameFull: McGuire DK
      – PersonEntity:
          Name:
            NameFull: Oldgren J
      – PersonEntity:
          Name:
            NameFull: Storey RF
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 12
              Text: 2025 Dec
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 2055-5822
          Numbering:
            – Type: volume
              Value: 12
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: ESC heart failure
              Type: main
ResultId 1